ACTRN12626000978369RecruitingNot Applicable
The effectiveness of different dose responses of shockwave therapy on pain, mobility, disability, and quality of life in adults with chronic non-specific low back pain
LINCOLN UNIVERSITY COLLEGE, MALAYSIA0 sites120 target enrollmentStarted: June 1, 2026Last updated:
Conditions
Interventions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 120
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 18 Years to 60 Years (—)
- Sex
- All
Inclusion Criteria
- •a) Adults aged 18–60 years
- •b) Physician Diagnosis of CNSLBP (More than 3 months)
- •c) The pain is typically located in the area between the costal margins (ribs) and
- •the gluteal folds.
- •a. Symptoms and Signs: The primary symptom is low back pain (LBP). This may
- •be included with or without referred leg pain (e.g., pain above the knee), as long
- •as it does not meet the criteria for a specific pathology like radiculopathy.
- •d) Visual Analogue Scale (VAS) pain score equal or more than 3/10
- •e) Oswestry Disability Index (ODI) equal or more than 30 %
- •f) Able to follow instructions and complete questionnaires
Exclusion Criteria
- •a) Specific LBP causes: disc herniation, spinal stenosis, spondylolisthesis,
- •ankylosing spondylitis, tumors, fractures, infections
- •b) Neurological deficits
- •c) Pregnancy
- •d) Contraindications to shockwave therapy (anticoagulant therapy, metal implants
- •in region, coagulation disorders, severe osteoporosis)
- •e) Severe psychological conditions that might confound the pain or treatment
- •response MINI Cog (e.g., severe depression, active substance abuse).
Arms & Interventions
Dose–Response Extracorporeal Shockwave Therapy (ESWT) Program for Chronic Non-Specific Low Back Pain
Intervention: Dose–Response Extracorporeal Shockwave Therapy (ESWT) Program for Chronic Non-Specific Low Back Pain
Investigators
Similar Trials
Completed
Phase 1
A study to evaluate the effect of multiple doses of carbamazepine on how long aticaprant (JNJ-67953964) stays in the body (pharmacokinetics) in healthy adults2022-502951-77-00Janssen - Cilag International20
Recruiting
Phase 1
A research study looking at how different doses of study medicine (Inno8) work in the body of people with haemophilia A2025-520490-38-00Novo Nordisk A/S16
Recruiting
Phase 1
A research study looking into how a single dose of the medicine NNC0537-1482 moves through the body of participants with normal or reduced kidney functionHeart failure with preserved ejection fraction2026-525271-57-00Novo Nordisk A/S54
Recruiting
Phase 1
A study to investigate how a single dose of the drug melflufen reaches brain tumor tissue, and how it affects the tumour, in patients who are already scheduled for surgery for a returning glioblastomaRecurrent glioblastoma2026-525543-32-00Oncopeptides AB10
Recruiting
Phase 1
A study to see how a single increasing dose of the oral drug AD-700 affects the ability of a CT scan to detect activated brown fat in healthy people2025-520584-41-00Adiposs S.A.18